The invention discloses a pharmaceutical composition for treating humid heat and
blood stasis type
pelvic inflammation. The pharmaceutical composition is composed of the following raw materials: 25-30 parts of
salvia miltiorrhiza, 12-16 parts of red paeony roots, 14-20 parts of fructus
forsythia, 12-18 parts of spina gleditsiae, 28-32 parts of sargentgloryvine stems, 16-20 parts of
patrinia, 10-15 parts of processed
myrrh, 10-15 parts of processed
frankincense, 15-20 parts of
corydalis tuber processed with vinegar, 10-14 parts of dried body of
ground beetle, 28-32 parts of stir-baked rhizoma dioscoreae, 28-35 parts of
semen coicis, 10-14 parts of
angelica sinensis, 28-33 parts of teasel roots, 25-30 parts of astragali radix and 10-15 parts of garden
balsam stem. According to the pharmaceutical composition disclosed by the invention, the selected medicinal materials are appropriate in compatibility, the formula is refined, the methods for tonifying qi, warming meridians, activating yang, promoting
blood circulation to
remove blood stasis and dredging collaterals are used, and clysis
drug delivery is adopted, so that the
drug can directly reach the
lesion, pelvic
blood supply is improved, and absorption of inflammatory exudation and release of
adhesive tissues can be promoted. Therefore, the
disease is rapidly improved, and the pharmaceutical composition is worthy of clinical popularization and application.